International Stem Cell Corp (ISCO)
0.065
-0.01
(-8.71%)
USD |
OTCM |
Apr 24, 16:00
International Stem Cell Enterprise Value: 2.394M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 2.394M |
| April 23, 2024 | 2.444M |
| April 22, 2024 | 2.444M |
| April 19, 2024 | 2.444M |
| April 18, 2024 | 2.444M |
| April 17, 2024 | 2.444M |
| April 16, 2024 | 2.443M |
| April 15, 2024 | 2.587M |
| April 12, 2024 | 2.834M |
| April 11, 2024 | 2.834M |
| April 10, 2024 | 2.480M |
| April 09, 2024 | 2.394M |
| April 08, 2024 | 2.674M |
| April 05, 2024 | 2.674M |
| April 04, 2024 | 2.674M |
| April 03, 2024 | 2.674M |
| April 02, 2024 | 2.622M |
| April 01, 2024 | 2.696M |
| March 28, 2024 | 2.696M |
| March 27, 2024 | 2.696M |
| March 26, 2024 | 2.363M |
| March 25, 2024 | 2.674M |
| March 22, 2024 | 2.291M |
| March 21, 2024 | 2.559M |
| March 20, 2024 | 2.559M |
| Date | Value |
|---|---|
| March 19, 2024 | 2.434M |
| March 18, 2024 | 2.554M |
| March 15, 2024 | 2.554M |
| March 14, 2024 | 2.754M |
| March 13, 2024 | 2.754M |
| March 12, 2024 | 2.674M |
| March 11, 2024 | 2.674M |
| March 08, 2024 | 2.674M |
| March 07, 2024 | 2.674M |
| March 06, 2024 | 2.674M |
| March 05, 2024 | 2.674M |
| March 04, 2024 | 2.674M |
| March 01, 2024 | 2.714M |
| February 29, 2024 | 2.494M |
| February 28, 2024 | 2.494M |
| February 27, 2024 | 2.522M |
| February 26, 2024 | 2.522M |
| February 23, 2024 | 2.517M |
| February 22, 2024 | 2.674M |
| February 21, 2024 | 2.834M |
| February 20, 2024 | 2.656M |
| February 16, 2024 | 2.656M |
| February 15, 2024 | 2.545M |
| February 14, 2024 | 2.545M |
| February 13, 2024 | 2.443M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.291M
Minimum
Mar 22 2024
10.01M
Maximum
Feb 12 2021
5.598M
Average
5.853M
Median
Nov 27 2020
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 9.076M |
| Perspective Therapeutics Inc | 984.38M |
| Protalix BioTherapeutics Inc | 64.08M |
| Electromed Inc | 133.53M |
| Armata Pharmaceuticals Inc | 159.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.458M |
| Revenue (Quarterly) | 1.889M |
| Total Expenses (Quarterly) | 2.313M |
| EPS Diluted (Quarterly) | -0.04 |
| Gross Profit Margin (Quarterly) | 54.31% |
| Profit Margin (Quarterly) | -24.25% |
| Earnings Yield | -52.69% |
| Normalized Earnings Yield | -52.69 |